Clinical Reference Laboratory Creates Unique Position in South America
Clinical Reference Laboratory
(CRL), has announced the full integration of its Argentina-based partner Laboratorio Hidalgo to its worldwide network of laboratories providing a much desired South American presence.
The agreement follows a long-standing laboratory partnership between the two companies and provides enhanced clinical trial support for CRL clients performing trials across North and South America. In addition, it puts CRL in the unique position of having immediate oversight and analysis of all clinical trial samples collected in South America through one system.
The integration of Laboratorio Hidalgo’stesting platforms into CRL’s proprietary LIMSystem will provide an expanded and full global project capability while building on Hidalgo’s renowned experience and reputation leading trials in South America.
Tim Sotos, chief executive officer of CRL, said: “Our expanding worldwidenetwork provides us with a solid foundation for delivering a truly global clinical trials support service to our international clients.”
CRL’s worldwide laboratory network provides clients with the global oversight that is necessary to supervise their trials. Clinical trial data from samples drawn anywhere in the world will be accessible in real time, enabling drug safetyevaluation and global tracking of samples at any point in the process.
Dr. Elisa Hidalgo, owner and clinical trials director at Laboratorio Hidalgo, said: “Our philosophy at Laboratorio Hidalgo is to offer integrated solutions tailored to our customers’ needs and this formalised partnership with CRL reinforces this message and shows a major commitment to our ongoing relationship.”
CRL is one of the largest privately-held laboratories in the USA offering central laboratory services for the support of clinical trials to the global pharmaceutical and biotechnology industry. It also has a wholly-owned CAP-accredited European operation in Cambridge, UK and has a proven track record in providing complete central laboratory solutions to support more than 4,000 clinical trials across the globe.
This agreement with Laboratorio Hidalgo in South America comes only a month after CRL announced its first worldwide laboratory integration with Phoenix Pharma Central Services in Singapore.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
